Human dendritic cell expression of HLA-DO is subset specific and regulated by maturation

Journal of Immunology

Volumn 176, Issue 6, 2006, Pages 3536-3547

  Hornell, Tara M C ^a   Burster, Timo ^a   Jahnsen, Frode L ^b   Pashine, Achal ^a,d   Ochoa, Maria T ^c   Harding, James J ^a   Macaubas, Claudia ^a   Lee, Andrew W ^a   Modlin, Robert L ^c   Mellins, Elizabeth D ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d ROCHE BIOSCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD123 ANTIGEN; HLA DO ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; BONE MARROW CELL; CELL MATURATION; CELL TYPE; DENDRITIC CELL; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LANGERHANS CELL; MACROPHAGE ACTIVATION; MONOCYTE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; T LYMPHOCYTE SUBPOPULATION; TISSUE SECTION;

EID: 33644845394     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.6.3536     Document Type: Article

References (50)

1. Busch, R., C. H. Rinderknecht, S. Roh, A. Lee, J. J. Harding, T. Burster, T. M. C. Hornell, and E. D. Mellins. 2005. Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression. Immunol. Rev. 207: 242-60.
2. Liljedahl, M., T. Kuwana, W. P. Fung-Leung, M. R. Jackson, P. A. Peterson, and L. Karlsson. 1996. HLA-DO is a lysosomal resident which requires association with HLA-DM for efficient intracellular transport. EMBO J. 15: 4817-4824.
3. Fallas, J. L., H. M. Tobin, O. Lou, D. Guo, D. B. Sant'Angelo, and L. K. Denzin. 2004. Ectopic expression of HLA-DO in mouse dendritic cells diminishes MHC class II antigen presentation. J. Immunol. 173: 1549-1560.
4. Bellemare-Pelletier, A., J. Tremblay, S. Beaulieu, M. R. Boulassel, J. P. Routy, B. Massie, R. Lapointe, and J. Thibodeau. 2005. HLA-DO transduced in human monocyte-derived dendritic cells modulates MHC class II antigen processing. J. Leukocyte Biol. 78: 95-105.
5. Chen, X., O. Laur, T. Kambayashi, S. Li, R. A. Bray, D. A. Weber, L. Karlsson, and P. E. Jensen. 2002. Regulated expression of human histocompatibility leukocyte antigen (HLA)-DO during antigen-dependent and antigen-independent phases of B cell development. J. Exp. Med. 195: 1053-1062.
6. Glazier, K. S., S. B. Hake, H. M. Tobin, A. Chadbum, E. J. Schattner, and L. K. Denzin. 2002. Germinal center B cells regulate their capability to present antigen by modulation of HLA-DO. J. Exp. Med. 195: 1063-1069.
7. Liljedahl, M., O. Winqvist, C. D. Surh, P. Wong, K. Ngo, L. Teyton, P. A. Peterson, A. Brunmark, A. Y. Rudensky, W. P. Fung-Leung, and L. Karlsson. 1998. Altered antigen presentation in mice lacking H2-O. Immunity 8: 233-243.
8. Denzin, L. K., D. B. Sant' Angelo, C. Hammond, M. J. Surman, and P. Cresswell. 1997. Negative regulation by HLA-DO of MHC class II-restricted antigen processing. Science 278: 106-109.
9. van Ham, S. M., E. P. Tjin, B. F. Lillemeier, U. Gruneberg, K. E. van Meijgaarden, L. Pastoors, D. Verwoerd, A. Tulp, B. Canas, D. Rahman, et al. 1997. HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading. Curr. Biol. 7: 950-957.
10. van Ham, M., M. van Lith, B. Lillemeier, E. Tjin, U. Gruneberg, D. Rahman, L. Pastoors, K. van Meijgaarden, C. Roucard, J. Trowsdale, et al. 2000. Modulation of the major histocompatibility complex class II-associated peptide repertoire by human histocompatibility leukocyte antigen (HLA)-DO. J. Exp. Med. 191: 1127-1136.
11. Perraudeau, M., P. R. Taylor, H. J. Stauss, R. Lindstedt, A. E. Bygrave, D. J. Pappin, S. Ellmerich, A. Whitten, D. Rahman, B. Canas, et al. 2000. Altered major histocompatibility complex class II peptide loading in H2-O-deficient mice. Eur. J. Immunol. 30: 2871-2880.
12. Karlsson, L., C. D. Surh, J. Sprent, and P. A. Peterson. 1991. A novel class II MHC molecule with unusual tissue distribution. Nature 351: 485-488.
13. Surh, C. D., E. K. Gao, H. Kosaka, D. Lo, C. Ahn, D. B. Murphy, L. Karlsson, P. Peterson, and J. Sprent. 1992. Two subsets of epithelial cells in the thymic medulla. J. Exp. Med. 176: 495-505.
14. Douek, D. C., and D. M. Altmann. 1997. HLA-DO is an intracellular class II molecule with distinctive thymic expression. Int. Immunol. 9: 355-364.
15. Chalouni, C., J. Banchereau, A. B. Vogt, V. Pascual, and J. Davoust. 2003. Human germinal center B cells differ from naive and memory B cells by their aggregated MHC class II-rich compartments lacking HLA-DO. Int. Immunol. 15: 457-466.
16. Rohn, T. A., M. Boes, D. Wolters, S. Spindeldreher, B. Muller, H. Langen, H. Ploegh, A. B. Vogt, and H. Kropshofer. 2004. Upregulation of the CLIP self peptide on mature dendritic cells antagonizes T helper type 1 polarization. Nat. Immunol 5: 909-918.
17. Hornell, T. M., C. G. W. Beresford, A. Bushey, J. M. Boss, and E. D. Mellins. 2003. Regulation of the class II MHC pathway in primary human monocytes by granulocyte-macrophage colony-stimulating factor. J. Immunol. 171: 2374-2383.
18. Bertho, N., B. Drenou, B. Laupeze, C. L. Berre, L. Amiot, J. M. Grosset, O. Fardel, D. Charron, N. Mooney, and R. Fauchet. 2000. HLA-DR-mediated apoptosis susceptibility discriminates differentiation stages of dendritic/monocytic APC. J. Immunol. 164: 2379-2385.
19. Geissmann, F., C. Prost, J. P. Monnet, M. Dy, N. Brousse, and O. Hermine. 1998. Transforming growth factor β1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J. Exp. Med. 187: 961-966.
20. Strobl, H., C. Bello-Fernandez, E. Riedl, W. F. Pickl, O. Majdic, S. D. Lyman, and W. Knapp. 1997. fit3 ligand in cooperation with transforming growth factor-/31 potentiates in vitro development of Langerhans-type dendritic cells and allows single-cell dendritic cell cluster formation under serum-free conditions. Blood 90: 1425-1434.
21. Hertel, L., V. G. Lacaille, H. Strobl, E. D. Mellins, and E. S. Mocarski. 2003. Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus. J. Virol. 77: 7563-7574.
22. Morris, P., J. Shaman, M. Attaya, M. Amaya, S. Goodman, C. Bergman, J. J. Monaco, and E. Mellins. 1994. An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature 368: 551-554.
23. Gladstone, P., and D. Pious. 1980. Identification of a trans-acting function regulation HLA-DR expression in a DR-negative B cell variant. Somatic Cell Genet. 6: 285-298.
24. Mellins, E., S. Kempin, L. Smith, T. Monji, and D. Pious. 1991. A gene required for class II-restricted antigen presentation maps to the major histocompatibility complex. J. Exp. Med. 174: 1607-1615.
25. Busch, R., A. Pashine, K. C. Garcia, and E. D. Mellins. 2002. Stabilization of soluble, low-affinity HLA-DM/HLA-DR1 complexes by leucine zippers. J. Immunol. Methods 263: 111-121.
26. Pashine, A., R. Busch, M. P. Belmares, J. N. Munning, R. C. Doebele, M. Buckingham, G. P. Nolan, and E. D. Mellins. 2003. Interaction of HLA-DR with an acidic face of HLA-DM disrupts sequence-dependent interactions with peptides. Immunity 19: 183-192.
27. Hochstenbach, F., V. David, S. Watkins, and M. B. Brenner. 1992. Endoplasmic reticulum resident protein of 90 kilodaltons associates with the T- and B-cell antigen receptors and major histocompatibility complex antigens during their assembly. Proc. Natl. Acad. Sci. USA 89: 4734-4738.
28. Drohan, L., J. J. Harding, B. Holm, E. Cordoba-Tongson, C. L. Dekker, T. Holmes, H. Maecker, and E. D. Mellins. 2004. Selective developmental defects of cord blood antigen-presenting cell subsets. Hum. Immunol. 65: 1356-1369.
29. Jahnsen, F. L., I. N. Farstad, J. P. Aanesen, and P. Brandtzaeg. 1998. Phenotypic distribution of T cells in human nasal mucosa differs from that in the gut. Am. J. Respir. Cell Mol. Biol. 18: 392-401.
30. Colonna, M., G. Trinchieri, and Y. J. Liu. 2004. Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5: 1219-1226.
31. Liu, Y. J. 2005. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 23: 275-306.
32. MacDonald, K. P., D. J. Munster, G. J. Clark, A. Dzionek, J. Schmitz, and D. N. Hart. 2002. Characterization of human blood dendritic cell subsets. Blood 100: 4512-4520.
33. Dzionek, A., A. Fuchs, P. Schmidt, S. Cremer, M. Zysk, S. Miltenyi, D. W. Buck, and J. Schmitz. 2000. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J. Immunol. 165: 6037-6046.
34. Schakel, K., E. Mayer, C. Federle, M. Schmitz, G. Riethmuller, and E. P. Rieber. 1998. A novel dendritic cell population in human blood: one-step immunomagnetic isolation by a specific mAb (M-DC8) and in vitro priming of cytotoxic T lymphocytes. Eur. J. Immunol. 28: 4084-4093.
35. - dendritic cells. Clin. Immunol. 100: 325-338.
36. Passlick, B., D. Flieger, and H. W. Ziegler-Heitbrock. 1989. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 74: 2527-2534.
37. Summers, K. L., B. D. Hock, J. L. McKenzie, and D. N. Hart. 2001. Phenotypic characterization of five dendritic cell subsets in human tonsils. Am. J. Pathol. 159: 285-295.
38. Patil, N. S., A. Pashine, M. P. Belmares, W. Liu, B. Kaneshiro, J. Rabinowitz, H. McConnell, and E. D. Mellins. 2001. Rheumatoid arthritis (RA)-associated HLA-DR alleles form less stable complexes with class II-associated invariant chain peptide than non-RA-associated HLA-DR alleles. J. Immunol. 167: 7157-7168.
39. Johnson, J. P., T. Meo, G. Riethmuller, D. J. Schendel, and R. Wank. 1982. Direct demonstration of an HLA-DR allotypic determinant on the low molecular weight (β) subunit using a mouse monoclonal antibody specific for DR3. J. Exp. Med. 156: 104-111.
40. Drover, S., R. W. Karr, X. T. Fu, and W. H. Marshall. 1994. Analysis of monoclonal antibodies specific for unique and shared determinants on HLA-DR4 molecules. Hum. Immunol. 40: 51-60.
41. Geissmann, F., S. Jung, and D. R. Littman. 2003. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19: 71-82.
42. + subset of IL-10-induced dendritic cells with reduced allostimulatory capacity in vitro. Eur. J. Immunol. 34: 2800-2811.
43. Galibert, L., G. S. Diemer, Z. Liu, R. S. Johnson, J. L. Smith, T. Walzer, M. R. Comeau, C. T. Rauch, M. F. Wolfson, R. A. Sorensen, et al. 2005. Nectin-like protein 2 defines a subset of T-cell zone dendritic cells and is a ligand for class-I restricted T-cell associated molecule. J. Biol. Chem. 280: 21955-21964.
44. Chamuleau, M. E., Y. Souwer, S. M. Van Ham, A. Zevenbergen, T. M. Westers, J. Berkhof, C. J. Meijer, A. A. van de Loosdrecht, and G. J. Ossenkoppele. 2004. Class II-associated invariant chain peptide expression on myeloid leukemic blasts predicts poor clinical outcome. Cancer Res. 64: 5546-5550.
45. Roucard, C., C. Thomas, M. A. Pasquier, J. Trowsdale, J. J. Sotto, J. Neefjes, and M. van Ham. 2001. In vivo and in vitro modulation of HLA-DM and HLA-DO is induced by B lymphocyte activation. J. Immunol. 167: 6849-6858.
46. Tonnelle, C., R. DeMars, and E. O. Long. 1985. DO β: a new β chain gene in HLA-D with a distinct regulation of expression. EMBO J. 4: 2839-2847.
47. Taxman, D. J., D. E. Cressman, and J. P. Ting. 2000. Identification of class II transcriptional activator-induced genes by representational difference analysis: discoordinate regulation of the DN α/DO β heterodimer. J. Immunol. 165: 1410-1416.
48. Jensen, P. E. 1998. Antigen processing: HLA-DO-a hitchhiking inhibitor of HLA-DM. Curr. Biol. 8: R128-R131.
49. Olsen, N. J., J. H. Moore, and T. M. Aune. 2004. Gene expression signatures for autoimmune disease in peripheral blood mononuclear cells. Arthritis Res. Ther. 6: 120-128.
50. Chen, X., L. M. Reed-Loisel, L. Karlsson, and P. E. Jensen. 2006. H2-O expression in primary dendritic cells. J. Immunol. In press.